Edition:
United States

Tocagen Inc (TOCA.OQ)

TOCA.OQ on NASDAQ Stock Exchange Global Select Market

9.13USD
18 Jul 2018
Change (% chg)

-- (--)
Prev Close
$9.13
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
34,388
52-wk High
$14.49
52-wk Low
$8.32

Select another date:

Wed, May 23 2018

BRIEF-Tocagen Entered Amended And Restated Loan And Security Agreement For $26.5 Mln

* TOCAGEN - ENTERED AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT FOR $26.5 MILLION AS TERM LOANS FUNDED ON EFFECTIVE DATE - SEC FILING Source text: (https://bit.ly/2IEQjX8) Further company coverage:

BRIEF-Tocagen Reports Q1 Loss Per Share $0.65

* TOCAGEN REPORTS FIRST QUARTER 2018 FINANCIAL AND BUSINESS RESULTS

BRIEF-Tocagen And ApolloBio Enter License Agreement To Develop Toca 511 & Toca FC In Greater China

* TOCAGEN AND APOLLOBIO ENTER LICENSE AGREEMENT TO DEVELOP AND COMMERCIALIZE TOCA 511 & TOCA FC IN THE GREATER CHINA REGION

BRIEF-Tocagen Q4 Loss Per Share $0.55

* TOCAGEN REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL AND BUSINESS RESULTS

BRIEF-Tocagen Receives EMA Orphan Medicinal Product Designation For Toca 511 & Toca FC For Glioma Treatment

* TOCAGEN RECEIVES EUROPEAN MEDICINES AGENCY ORPHAN MEDICINAL PRODUCT DESIGNATION FOR TOCA 511 & TOCA FC FOR THE TREATMENT OF GLIOMA Source text for Eikon: Further company coverage:

Select another date: